MIRI vs Tempus AI
A detailed comparison to help you choose between MIRI and Tempus AI.
🏆
Verdict: Tempus AI wins
Tempus AI scores 4.1/5, edging out MIRI at 2.6/5. Cancer centers, molecular labs and health systems building precision-oncology programs that need sequencing, interpretation and data products under one roof — and pharma partners buying real-world data access.
MIRI AI-powered personalized health and wellness coaching | Tempus AI AI for precision medicine and clinical genomics | |
|---|---|---|
| Rating | 2.6 (1 review) | 4.1 (1 review) |
| Pricing Model | freemium | paid |
| Starting Price | Free tier available | From $1000/mo |
| Best For | Patients or clients of a partner clinic that issues access codes, and health and wellness operators evaluating a white-labeled AI coaching layer — not general consumers shopping for a health coach today. | Cancer centers, molecular labs and health systems building precision-oncology programs that need sequencing, interpretation and data products under one roof — and pharma partners buying real-world data access. |
| Free Tier | ||
| API Access | ||
| Team Features | ||
| Open Source | ||
| Tags | free tiermobile app | ssoteam features |
| Visit MIRI → | Visit Tempus AI → |
MIRI
Pros
- + Consumer apps exist on both iOS and Android and are free to download at time of writing, with a simple log-meals, log-medication, log-mood loop
- + The coaching content is shaped by named practitioners (the site lists lifestyle-medicine physician Dr. Poonam Desai among its advisors) rather than an anonymous model prompt
- + The B2B platform is well aimed at its actual buyer: white-labeled engagement between visits plus operator-facing churn-risk signals drawn from real behavior, not survey snapshots
- + Founding team combines consumer-scale engineering experience (Lyft lineage per the About page) with clinicians who have run behavioral health companies
- + Honest scope language on the About page about extending protocols rather than replacing clinicians
Cons
- - General consumer sign-up is closed at time of writing — the web product is clinic-code or waitlist only while the business pivots
- - No public pricing anywhere: no tiers, no self-serve checkout, not even a starting price for the platform
- - The current consumer app is nutrition-centric, narrower than the sleep, weight, stress, and eating coaching promised in the 2023-era listings
- - Near-zero independent review footprint and no published clinical validation or safety documentation for a product that touches medication logging
- - The '24/7 expert advice' framing in the listing conflates an always-on AI coach with human expert access, which the product does not appear to offer
Tempus AI
Pros
- + FY2025 revenue of $1.3B with 126% net revenue retention and >$1.1B remaining contract value — verifiable public-company financials, not marketing claims
- + Complete assay portfolio in one relationship: xT/xR comprehensive profiling, xF+ liquid biopsy, MRD monitoring, Ambry hereditary testing and OneOme pharmacogenomics (national launch July 2026)
- + Tempus One answered voice queries against the patient's own clinical and molecular profile in my testing, with report citations instead of generic text
- + Paige Predict extends the platform into digital pathology — 123 biomarkers predicted from standard H&E slides across 16 cancer types (vendor-published validation)
- + Trial matching is built into the report workflow, which is the practical bottleneck for oncology coordinators
Cons
- - No self-serve access, no trial, and no published pricing of any kind — the $1,000 entry figure floating around listings could not be verified
- - Oncology-first scope; primary care and non-oncology specialties have little reason to engage
- - Still net-loss-making (-$245.0M in 2025), and the portfolio is stitched from four recent acquisitions (Ambry, Paige, OneOme, Deep 6)
- - Model-performance and data-library claims are company-published; independent third-party validation is thinner than the press-release volume suggests
- - Enterprise sales motion means long procurement cycles for health systems
Frequently Asked Questions
Which is better, MIRI or Tempus AI?▼
Tempus AI scores higher at 4.1/5 vs 2.6/5 for MIRI, making it the better-rated option in our comparison.
What is the difference between MIRI and Tempus AI?▼
MIRI: AI health platform providing personalized wellness coaching, nutrition guidance, and fitness recommendations with 24/7 access to expert advice. Tempus AI: Tempus AI runs clinical and genomic sequencing and builds the diagnostics and data products used in precision oncology and other specialties.
Is MIRI or Tempus AI more affordable?▼
MIRI starts at €0/mo, Tempus AI starts at €1000/mo. Check the comparison table above for current pricing.
Stay in the loop
Get weekly updates on the best new AI tools, deals, and comparisons.
No spam. Unsubscribe anytime.